Pharmaceutical

Filter

Current filters:

None

Popular Filters

151 to 175 of 7202 results

Ph III trial for AbbVie’s elagolix meets endpoints

08-01-2015

US pharma major AbbVie and partner Neurocrine Biosciences have announced positive top-line results from…

AbbVieelagolixNeurocrine BiosciencesPharmaceuticalResearchWomen's Health

Helsinn gains exclusive rights to commercialize Pharmacosmos' Monofer in the USA

Helsinn gains exclusive rights to commercialize Pharmacosmos' Monofer in the USA

08-01-2015

Swiss oncology specialist Helsinn and Danish anemia drugmaker Pharmacosmos have entered into an agreement…

HelsinnHematologyLicensingMarkets & MarketingMonoferPharmaceuticalPharmacosmos

Increased R&D outsourcing by global pharma and biopharma driving CRO business

Increased R&D outsourcing by global pharma and biopharma driving CRO business

08-01-2015

Increased outsourcing of R&D activities is one of the main drivers of growth in the contract research…

CovanceMarkets & MarketingParexelPharmaceuticalProductionQuintiles

Novartis signs genome editing alliances with Intellia Therapeutics and Caribou Biosciences

Novartis signs genome editing alliances with Intellia Therapeutics and Caribou Biosciences

08-01-2015

Swiss drug major Novartis has signed collaboration and licensing agreements with Intellia Therapeutics…

GeneticsLicensingNovartisPharmaceuticalSwitzerland

Ferrer licenses Canadian rights for ozenoxacin to Cipher Pharma

07-01-2015

Privately-held Spanish pharmaceutical company Ferrer says it has licensed commercialization rights for…

CanadaCipher PharmaceuticalsDermatologicalsFerrerLicensingOzenoxacinPharmaceutical

Indian government plans to establish dynamic and balanced IPR policy

Indian government plans to establish dynamic and balanced IPR policy

07-01-2015

Even as US President Barack Obama is slated to be the chief guest at India's Republic Day Parade on January…

IndiaPatentsPharmaceuticalPoliticsUSA

Aveo Oncology appoints Michael Bailey as president

Aveo Oncology appoints Michael Bailey as president

07-01-2015

Aveo Oncology has appointed Michael Bailey as president, chief executive and director.

AVEO OncologyBoardroomOncologyPharmaceuticalUSA

FDA grants Soligenix Fast Track status for SGX301

FDA grants Soligenix Fast Track status for SGX301

07-01-2015

Late-stage biopharma company Soligenix has said that its SGX301 (synthetic hypericin) development program…

OncologyPharmaceuticalRegulationSGX301SoligenixUSA

Shield Therapeutics' MAA for Ferracru accepted for review by EMA

Shield Therapeutics' MAA for Ferracru accepted for review by EMA

07-01-2015

Independent UK pharma company Shield Therapeutics has received acceptance for review of the Marketing…

FerracruHematologyPharmaceuticalRegulationShield TherapeuticsUK

Pfizer enters race to develop Duchenne muscular dystrophy therapy

Pfizer enters race to develop Duchenne muscular dystrophy therapy

07-01-2015

US pharma giant Pfizer is the latest company to enter the race to develop a therapy for Duchenne muscular…

GeneticsPF-06252616PfizerPharmaceuticalResearchUSA

CHMP recommends approval of Newron/Zambon's Xadago for Parkinson's disease

CHMP recommends approval of Newron/Zambon's Xadago for Parkinson's disease

07-01-2015

Italy-based Newron Pharmaceuticals and its partner Zambon have received a recommendation from the Euroean…

ItalyNeurologicalNewron PharmaceuticalsPharmaceuticalRegulationXadagoZambon

ThromboGenics NV appoints Dominique Vanfleteren as chief financial officer

ThromboGenics NV appoints Dominique Vanfleteren as chief financial officer

07-01-2015

Ophthalmic specialist ThromboGenics NV has appointed Dominique Vanfleteren as chief financial officer.

BelgiumBoardroomOphthalmicsPharmaceuticalThromboGenics

Kamedis to enter Chinese skin care market

07-01-2015

Israeli pharma company Kamedis has announced that it will enter the Chinese skin care market this year.

IsraelKamedisPharmaceutical

Valneva to acquire Dukoral vaccine from Crucell

07-01-2015

France-based biotech firm Valneva has entered into an agreement with Crucell Holland (part of Johnson…

CrucellDukoralJohnson & JohnsonMergers & AcquisitionsPharmaceuticalVaccinesValneva

Actavis’ Namenda appeal expedited to February

Actavis’ Namenda appeal expedited to February

07-01-2015

Ireland-headquartered generics major Actavis has had its motion to expedite its appeal of a lower court…

ActavisAppellate reviewLawLegalNamendaNeurologicalPharmaceuticalUSA

Asia-Pacific type 2 diabetes market to hit $10.5 billion by 2020

06-01-2015

The type 2 diabetes treatment market in Asia-Pacific (APAC) region will rise in value from an estimated…

Asia-PacificChinaDiabetesIndiaMarkets & MarketingmetforminPharmaceutical

Columbia Labs appoints Bridget Martell to newly-created chief medical officer position

Columbia Labs appoints Bridget Martell to newly-created chief medical officer position

06-01-2015

Women’s health specialist Columbia Laboratories has appointed Bridget Martell to the newly-created…

BoardroomBridget MartellCOL-1077Columbia LaboratoriesPharmaceuticalWomen's Health

Overall safety of measles-mumps-rubella-varicella vaccine confirmed by 12-year study

Overall safety of measles-mumps-rubella-varicella vaccine confirmed by 12-year study

06-01-2015

A 12-year study published in the journal Pediatrics has confirmed the safety of two measles-containing…

MedicinePharmaceuticalResearchVaccine Study CenterVaccines

CVS to cover Gilead’s hepatitis C drugs Harvoni and Sovaldi exclusively

CVS to cover Gilead’s hepatitis C drugs Harvoni and Sovaldi exclusively

06-01-2015

US pharmacy benefits manager CVS Health has entered into a deal with US biotech major Gilead Sciences…

GileadHarvoniNephrology and HepatologyPharmaceuticalPricingSovaldiUSA

151 to 175 of 7202 results

Back to top